J P Docherty

Author PubWeight™ 41.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch Gen Psychiatry 1989 6.63
2 The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Med 2000 1.81
3 A review of child psychotherapy research since 1963. J Am Acad Child Adolesc Psychiatry 1991 1.68
4 Preparing psychiatric residents for managed care. Values, proficiencies, curriculum, and implications for psychotherapy training. J Psychother Pract Res 1997 1.41
5 Consensus methods in practice guideline development: a review and description of a new method. Psychopharmacol Bull 1997 1.37
6 Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry 1990 1.35
7 The Expert Consensus Guideline Series. Treatment of behavioral emergencies. Postgrad Med 2001 1.31
8 Prevalence of seasonal affective disorder at four latitudes. Psychiatry Res 1990 1.25
9 The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients. Postgrad Med 2001 1.24
10 The Expert Consensus Guideline Series. Treatment of depression in women. Postgrad Med 2001 1.16
11 Pharmacotherapy of depression in older patients: a summary of the expert consensus guidelines. J Psychiatr Pract 2001 1.16
12 Treatment of depression in women: a summary of the expert consensus guidelines. J Psychiatr Pract 2001 0.99
13 Stages of onset of schizophrenic psychosis. Am J Psychiatry 1978 0.95
14 The Expert Consensus Guidelines for treating depression in bipolar disorder. J Clin Psychiatry 1998 0.94
15 Onset conditions for psychosomatic symptoms: a comparative review of immediate observation with retrospective research. Psychosom Med 1973 0.93
16 Psychological factors in the prognosis of malignant melanoma: a prospective study. Psychosom Med 1979 0.89
17 Gingival crevicular stromelysin, collagenase and tissue inhibitor of metalloproteinases levels in healthy and diseased sites. J Clin Periodontol 1995 0.88
18 Medication treatment of bipolar disorder 2000: a summary of the expert consensus guidelines. J Psychiatr Pract 2000 0.88
19 Conceptual and methodological issues in comparative studies of psychotherapy and pharmacotherapy, I: Active ingredients and mechanisms of change. Am J Psychiatry 1988 0.88
20 Psychotherapy and pharmacotherapy: conceptual lenses. Am J Psychiatry 1977 0.88
21 Diazepam in schizophrenia: a preliminary double-blind trial. Am J Psychiatry 1982 0.83
22 Tricyclics, bioequivalence, and clinical response. Am J Psychiatry 1978 0.82
23 d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia. Am J Psychiatry 1982 0.82
24 Conceptual and methodological issues in comparative studies of psychotherapy and pharmacotherapy, II: Nature and timing of treatment effects. Am J Psychiatry 1988 0.81
25 Algorithms for the treatment of subtypes of unipolar major depression. Psychopharmacol Bull 1995 0.80
26 Use of antidepressant drugs in schizophrenia. Arch Gen Psychiatry 1978 0.80
27 Platelet MAO and amitriptyline treatment. Psychiatry Res 1980 0.80
28 Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophrenia. Psychopharmacology (Berl) 1985 0.79
29 Nicotine dependence: perspectives on a new guideline from APA. Am J Psychiatry 1996 0.78
30 Acute amphetamine response predicts antidepressant and antipsychotic responses to lithium carbonate in schizophrenic patients. Psychiatry Res 1981 0.78
31 Effects of dopamine blockade on gonadotropins and testosterone in men. Am J Psychiatry 1980 0.78
32 A context analysis of psychological states prior to petit mal EEF paroxysms. J Nerv Ment Dis 1975 0.78
33 Dopamine receptor supersensitivity and schizophrenia: a review. Schizophr Bull 1981 0.76
34 O tempora, O mores: directions in research on the psychotherapeutic treatment of schizophrenia. Schizophr Bull 1984 0.76
35 Platelet MAO Vmax and Km in chronic schizophrenic subjects. Am J Psychiatry 1980 0.75
36 Thiazide-induced hypercalcemia in a manic-depressive patient. Am J Psychiatry 1980 0.75
37 Standards of care and clinical algorithms for treating schizophrenia. Psychiatr Clin North Am 1998 0.75
38 The assessment of outcome and value of psychiatric hospital treatment. New Dir Ment Health Serv 1994 0.75
39 Antipsychotic effects of pimozide in schizophrenia. Treatment response prediction with acute dextroamphetamine response. Arch Gen Psychiatry 1982 0.75
40 Lack of behavioral supersensitivity to d-amphetamine after pimozide withdrawal. A trial with schizophrenic patients. Arch Gen Psychiatry 1980 0.75
41 Comorbidity of personality disorders: two for the price of three. New Dir Ment Health Serv 1990 0.75
42 Integrative and sealing-over recoveries from schizophrenia: distinguishing case studies. Psychiatry 1976 0.75
43 Poor outcome and low platelet MAO activity in chronic schizophrenia. Am J Psychiatry 1984 0.75
44 A new concept and finding in morbid jealousy. Am J Psychiatry 1976 0.75
45 Intrapsychic structural effects of psychiatric research. Am J Psychiatry 1979 0.75
46 Chronic amitriptyline toxicity. Am J Psychiatry 1979 0.75
47 Predicting drug-free improvement in schizophrenic psychosis. Arch Gen Psychiatry 1979 0.75
48 Amphetamine-induced catecholamine activation in schizophrenia and depression: behavioral and physiological effects. Adv Biochem Psychopharmacol 1977 0.75
49 Prediction of early relapse after pimozide discontinuation by response to d-amphetamine during pimozide treatment. Biol Psychiatry 1982 0.75
50 A comprehensive system for value accounting in psychiatry. J Ment Health Adm 1996 0.75
51 Long-term pimozide pretreatment differentially affects behavioral responses to dextroamphetamine in schizophrenia. Further exploration of the dopamine hypothesis of schizophrenia. Arch Gen Psychiatry 1982 0.75
52 Dialogue. Prescription for problems? Capitating mental health drugs--the great debate. Behav Healthc Tomorrow 1998 0.75
53 Subtypes of schizophrenia: descriptive models. Schizophr Bull 1979 0.75
54 The future of research in private psychiatric hospitals. Psychiatr Hosp 1985 0.75
55 Chlorpromazine and immunologic considerations of schizophrenia. Ann Intern Med 1980 0.75
56 Psychotherapy. Lancet 1984 0.75
57 An experience with patient role-playing in psychiatric education. J Med Educ 1980 0.75
58 Trends in emergency psychiatry in the last two decades. Am J Psychiatry 1981 0.75
59 d-Amphetamine raises serum prolactin in man: evaluations after chronic placebo, lithium and pimozide treatment. Life Sci 1978 0.75